Size-exclusion chromatography can identify faster-associating protein complexes and evaluate design strategies by Mayer, Chad L et al.
BioMed  Central
Page 1 of 8
(page number not for citation purposes)
BMC Research Notes
Open Access Short Report
Size-exclusion chromatography can identify faster-associating 
protein complexes and evaluate design strategies
Chad L Mayer1,2, W Kalani Snyder1, Monika A Swietlicka1, 
Andrew D VanSchoiack1, Chad R Austin1,3 and Benjamin J McFarland*1
Address: 1Department of Chemistry and Biochemistry, Seattle Pacific University, 3307 Third Avenue West, Seattle, WA 98119-1997, USA, 2Current 
address : Seattle Biomedical Research Institute, Seattle, WA 98109, USA and 3Current address : Dept. of Microbiology, University of Colorado – 
Denver, Aurora, CO 80045, USA
Email: Chad L Mayer - mayerc@spu.edu; W Kalani Snyder - kalani@spu.edu; Monika A Swietlicka - swietm@spu.edu; 
Andrew D VanSchoiack - vansca@gmail.com; Chad R Austin - chad.austin@ucdenver.edu; Benjamin J McFarland* - bjm@spu.edu
* Corresponding author    
Abstract
Background: We previously developed a set of rationally designed mutant MICA protein ligands
for the NKG2D immunoreceptor in which MICA was mutated at residues that do not contact
NKG2D. Some of these MICA mutants, predicted by RosettaDesign to be destabilized, bound
NKG2D with affinities enhanced by more than an order of magnitude when evaluated by surface
plasmon resonance (SPR).
Findings: Small-zone size-exclusion chromatography (SEC) detected persistent high-affinity MICA
mutant-NKG2D complexes in solution as early-eluting peaks. The SEC binding assay used standard
protein purification instrumentation to evaluate complex stability, qualitatively paralleled the SPR
results, and successfully discriminated among complexes that differed only in on-rates. We used
the SEC binding assay, along with SPR, to assess the results of a follow-up design strategy targeting
the non-interfacial redesigned region. Both SEC and SPR agreed that these mutations did not
enhance affinity as much as previous mutants. When the SEC binding assay was run in 1 M urea,
only the highest affinity complex was detected.
Conclusion: This SEC binding assay provides a correlation with SPR results for protein complex
affinities, detecting changes in complex on-rates, and tunable to lower sensitivity with 1 M urea.
The SEC binding assay is complementary to other protein design evaluation methods, can be
adapted to the undergraduate research laboratory, and may provide additional structural
information about changes in hydrodynamic radii from elution times. Our assay allowed us to
conclude that further alteration of MICA at non-contacting residues is unlikely to further enhance
NKG2D affinity.
Background
Several protein design algorithms have been produced
over the past decade for rationally altering and optimizing
the cores of proteins, protein-ligand interfaces, and pro-
tein-protein interfaces for structural and therapeutic
application [1], including RosettaDesign [2]. Protein
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design schemes require a step for screening a set of candi-
date proteins. Size-exclusion chromatography (SEC) is an
option for design evaluation if a protein's size is changed
significantly or a larger, high-affinity protein-protein com-
plex is formed. For protein-protein complexes, the SEC
column can be saturated with protein for a large-zone
assay [3], or a small plug of protein can be injected onto a
column for a small-zone assay [4,5]. Small-zone tech-
niques have been used for the MICA-NKG2D protein-pro-
tein interaction we investigate in this paper using small
(analytical) amounts of protein and detecting the pres-
ence or absence of persistent complexes [6], as a purifica-
tion step for MICA-NKG2D complex crystallization [7],
and for diverse ends with other proteins [8-10].
SEC has the technical advantages of preparative scale,
speed and cost-effectiveness relative to binding tech-
niques such as surface plasmon resonance (SPR). In addi-
tion, persistence of a complex through an SEC column
implies that the proteins physically adhered or equili-
brated quickly enough to effectively adhere on a scale of
minutes to hours, even as unbound molecules were parti-
tioned away by the action of the column. This physical
evidence that the protein-protein complex has been main-
tained over a long time shows that the complex has a sig-
nificant "residence time," a concept which has proved
useful for small-molecule drugs [11] and may be useful
for finding or characterizing potent designed-protein
drugs or receptor-ligand complexes [12].
Here we describe the full results a small-zone analytical
SEC protein-protein binding assay developed to probe the
design space for the MICA-NKG2D interaction, which was
mentioned but not detailed in a previous publication
[13]. MICA binds homodimeric NKG2D on the surface of
certain immunocytes, triggering the death of stressed cells
such as transformed cancerous cells [14]. We previously
described how a set of 25 mutant MICA proteins was
made in which eight MICA residues were varied [13].
These mutations were not located directly at the NKG2D-
MICA binding interface, but were below it, located within
and under the α2 helix (Figure 1). This atypical design
strategy produced unexpected results: MICA proteins with
lower design scores, predicting more stable MICA pro-
teins, bound NKG2D with the same or weaker affinity,
while some MICA proteins with higher design scores, pre-
dicting that the MICA proteins themselves would be less
stable, bound NKG2D with greater affinity [13]. Here we
report the complete results of our SEC binding assay and
correlate them with the previously reported thermody-
namic and kinetic results [13] obtained by surface plas-
mon resonance (SPR). We also extend the data set with
follow-up MICA designs, bringing to conclusion our anal-
ysis of destabilizing design strategies.
Results
SEC binding assays can detect stabilized protein 
complexes in the micromolar-to-nanomolar range
Steinle et al. observed that recombinantly produced and
refolded NKG2D, mixed with wild-type MICA and
injected onto an SEC column, eluted as an early shoulder
to the unbound protein peak, at a molecular weight corre-
sponding to a ~60 kDa complex rather than its individual
~30 kDa components. [6] We observed the same results
with our preparations of wild-type MICA mixed with
Location of disordered region and design mutations in the  MICA structure Figure 1
Location of disordered region and design mutations 
in the MICA structure. (a) The receptor-bound structure 
of MICA (Protein Data Bank ID 1HYR chain C) in stereo, 
shown as ribbons and colored by PDB-assigned secondary 
structure of unbound MICA (PDB ID 1B3J), with beta sheets 
red, helices yellow and loops green. (Residues in the α2 helix 
of receptor-bound MICA that are absent from the crystal 
structure of unbound MICA are colored green.) The solvent-
accessible surface of unbound MICA is overlaid on the recep-
tor-bound structure with the same coloring, showing how 
the disordered region exposes the underlying beta-sheet. (b) 
Side view in stereo of the receptor-bound wild-type MICA 
structure used by RosettaDesign, with the helix backbone 
that is not observed in the unbound structure colored green. 
The eight redesigned residues are shown as sticks and 
labeled. The residues mutated in only the first design strat-
egy, summarized in Table 1, are colored blue, and the resi-
dues that were also mutated in the second design strategy, 
summarized in Table 2, are colored purple. Figures made 
with PyMol http://www.pymol.org.BMC Research Notes 2009, 2:135 http://www.biomedcentral.com/1756-0500/2/135
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Differences among NKG2D-mutant MICA complexes as observed in the SEC binding assay Figure 2
Differences among NKG2D-mutant MICA complexes as observed in the SEC binding assay. The elution profile of 
UV absorbance vs. time as constant flow resulting from an injection of NKG2D alone is shown as a gray line; MICA mutant or 
wild-type alone is shown as a dashed line; and NKG2D and MICA mutant or wild-type mixed in 2:1 molar ratios is shown as a 
solid line. The elution times of size standards under identical conditions are shown above each graph. Graphs are labelled with 
the specific representative mutant. (a) Some mutants elute as a ~60-kDa peak (++). (b-d) Some MICA mutants and wild-type 
elute with an early shoulder undifferentiated from the ~30-kDa unbound peak (+). (e-f) Some MICA mutants with stabilizing 
mutations elute only as a ~30-kDa peak aligned with the elution time of both proteins alone (-).
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Comparison of SPR and SEC binding assays for evaluation of redesigned MICA proteins Figure 3
Comparison of SPR and SEC binding assays for evaluation of redesigned MICA proteins. Each MICA mutant from 
Table 1 is organized according to the results of the SEC binding assay and graphed against a different parameter. The average of 
each category is shown as a vertical line. (a) SEC results compared to RosettaDesign score [13] shows that negative Rosetta-
Design scores (predicted stabilized) only have binding results similar to or worse than wild-type, while positive RosettaDesign 
scores (predicted destabilized) include all 5 MICA mutants found to bind more tightly than wild-type. SEC results compared to 
SPR results [13] from (b) equilibrium and (c-d) kinetic analysis show similar correlations between equilibrium affinity and on-
rate with the highest-affinity mutants by SEC, while no correlation with off-rate is seen because the set of mutants does not 
vary significantly in this parameter. Observed kon and koff rates from single-step kinetic fits for mutants predicted to be stabi-
lized, and from two-step kinetic fits for mutants predicted to be destabilized (k+1 and k-2, respectively). (P values for the differ-
ence between ++ and + complexes: t-test P = 0.0013 for Figure 3a; 0.0006 for Figure 3b; 0.0001 for Figure 3c; and 0.6 for 
Figure 3d.)
-9 -8 -7 -6 -5 -4 -3 -2 -1 0 1 2 3 4 5 6
-
+
++ a)
Design score relative to wild-type
S
E
C
 
b
i
n
d
i
n
g
-9.0 -8.5 -8.0 -7.5 -7.0 -6.5 -6.0
-
+
++ b)
G(equilibrium)
S
E
C
 
b
i
n
d
i
n
g
1 10 100 1000
-
+
++
c)
log (kon, obs)
S
E
C
 
b
i
n
d
i
n
g
1 10 100 1000
-
+
++ d)
log (koff,obs)
S
E
C
 
b
i
n
d
i
n
gBMC Research Notes 2009, 2:135 http://www.biomedcentral.com/1756-0500/2/135
Page 5 of 8
(page number not for citation purposes)
homodimeric NKG2D (Figure 2c), and repeated these
conditions for our set of redesigned MICA mutants (Fig-
ure 2). Some MICA mutants with high design scores (pre-
dicting MICA destabilization) mixed in a 1:2 molar ratio
with NKG2D eluted as a separate, early ~60 kDa peak (Fig-
ure 2a). When this early peak was collected and analyzed
by reducing SDS-PAGE, protein bands were observed at
the molecular weights corresponding to both MICA (30
kDa) and NKG2D (15 kDa). Other MICA mutants mixed
with NKG2D eluted as early shoulders to the 30-kDa peak
(Figure 2b and 2d), or as symmetrical ~30-kDa peaks (Fig-
ure 2e and 2f). A qualitative correlation can be observed
between SPR equilibrium ΔG of binding and SEC bind
assay results: Observation of an early shoulder corre-
sponds to a low-micromolar range of affinity like wild-
type MICA binding NKG2D. A differentiated early peak
corresponds to high-nanomolar binding, as with
MIC_N69W_K152E, and the absence of an early peak cor-
responds to low-to-mid-micromolar binding, as with
MIC_N69Q_Q120I_K154S_T155D_Y157L.
SEC binding assays can detect differences in protein-
protein on-rates
The SPR study showed that some high design scores are
associated with high affinity, and the SEC binding assay
leads to the same conclusion (Figure 3). Equilibrium
affinity agrees with the sets of protein binding strengths
described by the SEC binding assay. Our design strategy
altered non-contacting residues that did not change the
off-rates, but did cause a large difference in on-rates. The
SEC binding assay detected this, discriminating among
complexes that had significantly varying on-rates, and the
off-rates for this set of proteins were so similar that they
were not a significant factor.
Rationally designed MICA destabilization at single non-
contacting residues does not enhance NKG2D binding
A plot of NKG2D affinity vs. design score for the initial set
of 25 MICA mutants produced previously shows that an
area of design space was unfilled because the initial design
strategy was biased toward stabilizing mutations and no
MICA mutant was destabilized by more than 6 units. (Fig-
ure 4) After we found that mild MICA destabilization
increased NKG2D affinity by more than an order of mag-
nitude (Table 1), we then designed three more destabiliz-
ing mutants at the same locations to confirm if we were
past the point of "diminishing returns," at which
increased MICA destabilization would destabilize the
complex with NKG2D. Using RosettaDesign, non-
cysteine residues were modeled at residues 108, 154, and
157. Point mutations predicted to provide a range of large
disruptions to the wild-type structure were selected from
the candidate designs produced by Rosetta, and prepared
as previously reported [13]. In the SEC binding assay,
none bound NKG2D better than wild-type MICA (Table
2). SPR equilibrium analysis showed their affinities were
not significantly enhanced (Figure 4).
Destabilized mutants elute early in analytical SEC
In the SEC binding assay, the peak maximum of the
unbound MICA mutant would decrease, moving from 3.5
mL for mutants with design scores of 50 or below to 3.1
mL for higher design scores (Figure 5), increasing appar-
ent hydrodynamic radius from 23 Å to 25 Å (Table 2).
When the column was saturated with buffer containing 1
M urea, the two mutants with the largest predicted desta-
bilizations continued to elute early (Figure 5). The early-
eluting shoulders for wild-type and the point-destabilized
mutants were no longer observed. High-affinity
MICN69W_K152E_K154D when mixed with NKG2D still
eluted in 1 M urea as an early peak (Table 2).
Discussion
In this study SEC formed the basis of a simple binding
assay to assess protein-protein interaction strength, com-
Table 1: SEC evaluation of predicted stabilized or mildly 
destabilized MICA mutants
MIC Mutant Design Score SEC Binding
N69Q_Q108L_Q120I_K154S_T155D -8.1 +
N69Q_Q120I_K154S_T155D_Y157L -7.1 -
N69Q_D72F_K154S_T155D -7.1 +
N69Q_Q120I_K154S_T155D -6 +
N69Q_D72F_Q108L_K152V_Y157L -5.9 +
K152V_K154S_T155D_Y157L -5.8 +
N69Q_K154D -4.3 +
K154S_T155D -4 -
K152V_K154S_T155D -3.9 -
N69Q_D72F_Q108L -3.9 +
N69Q_D72F -3.6 +
N69Q -2.8 +
K152V_Y157L -2.2 +
K154D -1.5 +
Q108L -0.5 +
Wild-type 0 +
D72W 0.3 -
Q120I 0.7 +
Q120I_K154M 0.8 n/a
N69W 1.8 ++
N69W_K152E_K154S 4.2 ++
N69W_K152E_K154D 4.3 ++
K152E_K154M 4.4 +
N69W_D72F_K152E 4.5 ++
N69W_D72W_K152E 5.1 +
N69W_K152E 5.5 ++
Design scores are listed relative to wild-type. Results of SEC binding 
assay follow the examples in Figure 2; n/a, not applicable because 
unbound mutant did not elute from column due to non-specific 
binding.BMC Research Notes 2009, 2:135 http://www.biomedcentral.com/1756-0500/2/135
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plementary to SPR binding assays. SEC results alone could
evaluate the qualitative success or failure of exploring
these regions of design space, although without quantita-
tive kinetic or thermodynamic detail. The correlation of
SEC and SPR is similar to the correlation between SEC and
analytical ultracentrifugation (AUC) in that results from
the two techniques generally agree, with SEC using com-
mon equipment, but AUC considered the "gold standard"
[10,15-18]. AUC requires dedicated instrumentation,
while SEC uses protein purification equipment and is
faster [9]. SEC may be used to bring protein design to
undergraduate research programs with limited equipment
budgets, where the same pump used for protein chroma-
tography during purification can be used for design eval-
uation through an SEC binding assay. The range of
affinities that could be discriminated by the SEC binding
assay was appropriate to design of the low-micromolar
MICA-NKG2D interaction. Addition of 1 M urea to the
assay tuned it to be less sensitive to lower-affinity binding,
while still discriminating between our most successful
design and other candidates.
The relationship between elution time and protein-pro-
tein affinity has been modelled for small-zone SEC
emphasizing the role of the off-rate in determining com-
plex persistence. [4,5] Our data show that SEC can dis-
Table 2: SEC and SPR evaluation of predicted significantly destabilized MICA point mutants
Buffer + 0 M Urea
Elution Apparent Apparent
MIC Mutant Design Score ΔGeq
(kcal mol-1)
SEC Binding Volume (mL) MW (kDa) r
(Å)
WT 0 -7.3 ± 0.1 + 3.5 ± 0.1 30 ± 2 23 ± 2
N69W_K152E_K154D 4 -8.8 ± 0.1 ++ 3.4 ± 0.1 30 ± 2 23 ± 2
Y157W 50 -7.9 ± 0.1 - 3.6 ± 0.1 30 ± 2 23 ± 2
K154P 220 -7.6 ± 0.1 + 3.1 ± 0.1 34 ± 2 25 ± 2
Q108W 290 -7.8 ± 0.2 + 3.1 ± 0.1 34 ± 2 25 ± 2
Buffer + 1 M Urea
Elution Apparent Apparent
MIC Mutant SEC Binding Volume (mL) MW
(kDa)
r
(Å)
WT - 2.8 ± 0.1 38 ± 2 27 ± 3
N69W_K152E_K154D ++ 2.9 ± 0.1 37 ± 2 26 ± 3
Y157W - 2.8 ± 0.1 39 ± 2 27 ± 3
K154P - 2.6 ± 0.1 41 ± 3 28 ± 3
Q108W - 2.7 ± 0.1 40 ± 3 28 ± 3
Design scores are listed relative to wild-type. ΔG values determined at equilibrium by SPR. Wild-type and high-affinity MIC N69W_K152E_K154D 
SPR values as reported previously in [13]. Upper table shows SEC results with no added urea, and lower table shows SEC results in the presence of 
1 M additional urea. Results of SEC binding assay follow the examples in Figure 2. Elution volume measured relative to the elution time of blue 
dextran. Apparent molecular weight (MW) and radii (r) determined by line fit of elution time to Low Molecular Weight Standards (GE Healthcare). 
Standard errors are from triplicate experiments as described in Methods.
Comparison of the initial and follow-up design strategies Figure 4
Comparison of the initial and follow-up design strate-
gies. The difference in free energy of NKG2D binding rela-
tive to wild-type MICA is shown for each MICA mutant 
tested by SPR, from affinities determined at equilibrium. The 
RosettaDesign score relative to wild-type is plotted on the x-
axis. MICA mutants in the initial design set (internal stabiliza-
tion or destabilization; Table 1) are shown as open diamonds. 
MICA mutants from the follow-up design set (significant 
internal destabilization; Table 2) are shown as filled dia-
monds.
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criminate among complexes of different affinities that
primarily differ in on-rate. We hypothesize that a fast on-
rate can allow a complex to re-attach before substantial
separation, so that the complex remains in a small zone,
even if the off-rate is fast.
Unbound mutant proteins with point mutations that are
predicted to cause large destabilizations appear slightly
larger than wild-type MICA by SEC. The average hydrody-
namic radius of these proteins appears increased by desta-
bilization; a similar observation using SEC-light scattering
led to the conclusion that the protein in question was par-
tially denatured [16]. For partially disordered proteins,
the interplay between disorder and affinity is incom-
pletely understood. Research into the relationship
between dynamics and affinity may delineate which types
of disorder promote binding, such as fly-casting [19,20]
or ground-state destabilization [21], and which types of
disorder inhibit binding.
Conclusion
While the specific dynamic and structural impacts of the
destabilizing mutations are only hinted at by the
increased elution times of the SEC binding assay, the
impact of these mutations on binding affinity is clear, in
that none are stabilized in NKG2D affinity relative to
wild-type MICA by more than 0.5 kcal/mol, and none per-
sist through the column as a bound complex. We decided
from these results to target other regions for future design.
The persistence of a high-affinity complex through the
column even in the presence of 1 M urea could imply sig-
nificantly increased persistence time in the biological
environment as well.
Methods
Protein design and production
The set of mutants in Table 1 was designed and produced
as described previously [13]. Because the initial design
strategy focused on increasing the stability of MICA in the
region of the disordered loop, only 603 of 4608 designs
were predicted to destabilize the receptor-bound confor-
mation relative to wild-type. The set of mutants in Table 2
was designed to produce more destabilizing mutants.
RosettaDesign [2] v2.0 was used with the coordinates of
receptor-bound MICA from the NKG2D-MICA crystal
structure (PDB ID 1HYR) [7]. Three of the eight previously
altered locations at the center of the disordered region
located on different structural elements were chosen (Fig-
ure 1b). RosettaDesign was used to model the results of
mutating of each of these three residues to the 19 non-
cysteine amino acids with the backbone fixed to the recep-
tor-bound coordinates. Mutations with large positive
scores relative to wild-type were chosen for analysis.
Proteins were produced as described previously [13].
Before use in binding assays the proteins were dialyzed
into HBS-EA buffer (10 mM HEPES [pH 7.4], 150 mM
NaCl, 3 mM EDTA, and 0.02% sodium azide). Protein
concentrations were determined by Nanodrop ND-1000
(Thermo Scientific) absorbance at 280 nm and by bicin-
choninic (BCA) assay (Thermo Scientific).
SEC binding assays
20 μmol each of homodimeric NKG2D and the MIC-A
mutant were combined with HBS-EA buffer to a volume
of 300 μL, mixed and immediately injected onto a Super-
dex 75 10/300 gel-filtration column (GE Healthcare) with
a 500-μL loop at 0.5 mL/min using an AKTA PrimePlus
FPLC system (GE Healthcare). The eluting protein was
detected by UV absorbance at 280 nm. These were com-
pared to injections of 20 μmol of homodimeric NKG2D
or MICA alone. Columns were calibrated with Gel Filtra-
tion Calibration LMW standards (GE Healthcare: conal-
bumin, ovalbumin, carbonic anhydrase, and ribonuclease
Effect of 1 M urea on the elution profiles of MICA wild-type  and MIC_Q108W Figure 5
Effect of 1 M urea on the elution profiles of MICA 
wild-type and MIC_Q108W. Elution profiles of normal-
ized UV absorbance vs. elution volume for injections of 
MICA wild-type (black) and MIC_Q108W (blue) in HBS-EA; 
and for MICA wild-type (gray) and MIC_Q108W (light blue) 
in HBS-EA with 1 M urea added.
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A, and blue dextran for void volume determination; also
Sigma: cytochrome c). Several individual proteins and
mixed receptor-ligand complexes were injected three or
more times onto the same column, resulting in variations
in elution volume of no more than 0.1 mL. Fractions were
collected using the AKTA Prime fraction collector for anal-
ysis by reducing analytical SDS-PAGE using Coomassie
Blue staining. Observed variations in elution volume for
triplicate experiments with urea in the buffer were as listed
in Table 2.
SPR binding assays
For the first set of mutants (Table 1), determination of
NKG2D-mutant MICA kinetics and thermodynamics by
SPR was previously described [13]. NKG2D affinities for
the second set of MICA mutants (Table 2) were deter-
mined by equilibrium binding analysis as used in the pre-
vious study. (Fast kinetics precluded the use of kinetic
fits.) Standard errors reported in the data tables result
from triplicate (or more) experiments.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
CLM and WKS carried out SEC binding assays. WKS and
BJM carried out SPR binding assays. CLM, WKS, MAS,
ADV, and CRA designed, made and purified mutant pro-
teins. All authors participated in interpretation of the
data. CLM, WKS, CRA and BJM drafted the manuscript. All
authors have read and approved the final manuscript.
Acknowledgements
We thank Derek Wood and Kathryn Houmiel (Seattle Pacific University) 
for technical assistance and early evaluation of this research as student 
presentations, Tanja Kortemme (UCSF) for the initial design with Rosetta, 
and Roland Strong (Fred Hutchinson Cancer Research Center) for instru-
ment use. This research was funded by National Institutes of Health Grant 
R15 AI058972.
References
1. Kortemme T, Baker D: Computational design of protein-pro-
tein interactions.  Curr Opin Chem Biol 2004, 8(1):91-7.
2. Kortemme T, Baker D: A simple physical model for binding
energy hot spots in protein-protein complexes.  Proceedings of
the National Academy of Sciences of the United States of America 2002,
99(22):14116-14121.
3. Winzor DJ: Quantitative characterization of ligand binding by
chromatography.  In Protein-Ligand Interactions: Hydrodynamics and
Calorimetry: A Practical Approach Edited by: Harding SE, Chowdhry BZ.
Oxford: Oxford University Press; 2001:47-74. 
4. Stevens FJ: Analysis of protein-protein interaction by simula-
tion of small-zone size exclusion chromatography. Stochas-
tic formulation of kinetic rate contributions to observed
high-performance liquid chromatography elution character-
istics.  Biophys J 1989, 55(6):1155-1167.
5. Wilton R, Myatt EA, Stevens FJ: Analysis of protein-protein inter-
actions by simulation of small-zone gel filtration chromatog-
raphy.  In Protein-Protein Interactions: Methods and Protocols Volume
261. Edited by: Fu H. Totowa, NJ: Humana Press Inc; 2004:137-154. 
6. Steinle A, Li P, Morris DL, Groh V, Lanier LL, Strong RK, Spies T:
Interactions of human NKG2D with its ligands MICA, MICB,
and homologs of the mouse RAE-1 protein family.  Immunoge-
netics 2001, 53(4):279-287.
7. Li P, Morris DL, Willcox BE, Steinle A, Spies T, Strong RK: Complex
structure of the activating immunoreceptor NKG2D and its
MHC class I-like ligand MICA.  Nat Immunol 2001, 2(5):443-451.
8. Franzini M, Bramanti E, Ottaviano V, Ghiri E, Scatena F, Barsacchi R,
Pompella A, Donato L, Emdin M, Paolicchi A: A high performance
gel filtration chromatography method for gamma-glutamyl-
transferase fraction analysis.  Anal Biochem 2008, 374(1):1-6.
9. le Maire M, Arnou B, Olesen C, Georgin D, Ebel C, Moller JV: Gel
chromatography and analytical ultracentrifugation to deter-
mine the extent of detergent binding and aggregation, and
Stokes radius of membrane proteins using sarcoplasmic
reticulum Ca2+-ATPase as an example.  Nat Protoc 2008,
3(11):1782-95.
10. Gralle M, Oliveira CL, Guerreiro LH, McKinstry WJ, Galatis D, Mas-
ters CL, Cappai R, Parker MW, Ramos CH, Torriani I, et al.: Solution
conformation and heparin-induced dimerization of the full-
length extracellular domain of the human amyloid precursor
protein.  J Mol Biol 2006, 357(2):493-508.
11. Copeland RA, Pompliano DL, Meek TD: Drug-target residence
time and its implications for lead optimization.  Nat Rev Drug
Discov 2006, 5(9):730-9.
12. Tummino PJ, Copeland RA: Residence time of receptor-ligand
complexes and its effect on biological function.  Biochemistry
2008, 47(20):5481-5492.
13. Lengyel CS, Willis LJ, Mann P, Baker D, Kortemme T, Strong RK,
McFarland BJ: Mutations designed to destabilize the receptor-
bound conformation increase MICA-NKG2D association
rate and affinity.  J Biol Chem 2007, 282(42):30658-30666.
14. Strong RK, McFarland BJ: NKG2D and Related Immunorecep-
tors.  Adv Protein Chem 2004, 68:281-312.
15. Berkowitz SA: Role of analytical ultracentrifugation in assess-
ing the aggregation of protein biopharmaceuticals.  AAPS J
2006, 8(3):E590-605.
16. Philo JS: Is any measurement method optimal for all aggre-
gate sizes and types?   AAPS J 2006, 8(3):E564-71.
17. Gualfetti PJ, Iwakura M, Lee JC, Kihara H, Bilsel O, Zitzewitz JA, Mat-
thews CR: Apparent radii of the native, stable intermediates
and unfolded conformers of the alpha-subunit of tryptophan
synthase from E. coli, a TIM barrel protein.  Biochemistry 1999,
38(40):13367-13378.
18. Gabrielson JP, Brader ML, Pekar AH, Mathis KB, Winter G, Carpenter
JF, Randolph TW: Quantitation of aggregate levels in a recom-
binant humanized monoclonal antibody formulation by size-
exclusion chromatography, asymmetrical flow field flow
fractionation, and sedimentation velocity.  J Pharm Sci 2007,
96(2):268-79.
19. Hoffman RM, Blumenschein TM, Sykes BD: An interplay between
protein disorder and structure confers the Ca2+ regulation
of striated muscle.   J Mol Biol 2006, 361(4):625-33.
20. Shoemaker BA, Portman JJ, Wolynes PG: Speeding molecular rec-
ognition by using the folding funnel: the fly-casting mecha-
nism.  Proceedings of the National Academy of Sciences of the United
States of America 2000, 97(16):8868-8873.
21. Horn JR, Kraybill B, Petro EJ, Coales SJ, Morrow JA, Hamuro Y, Kos-
siakoff AA: The role of protein dynamics in increasing binding
affinity for an engineered protein-protein interaction estab-
lished by H/D exchange mass spectrometry.  Biochemistry 2006,
45(28):8488-8498.